Literature DB >> 8273591

Effect of protein kinase inhibitors on IL-8/NAP-1 release from human umbilical vein endothelial cells.

J R White1, J C Lee.   

Abstract

Several protein kinase inhibitors (PKIs) were investigated for their effects on IL-1 beta, TNF alpha and PMA-induced IL-8 production from human umbilical vein endothelial cells (HUVEC). IL-1 beta (ED50 0.07 ng/ml), TNF alpha (ED50 100 ng/ml) and PMA (ED50 20 ng/ml) induced IL-8 production that could be detected as early as 2 h following stimulation. Staurosporine, a potent but non-specific inhibitor of protein kinases, inhibited PMA-induced (IC50 2 nM) but not IL-1 beta or TNF alpha (IC50 > 200 nM) induced IL-8 production. Neither the cAMP-dependent PKI, KT5720, nor the tyrosine PKIs, genistein, tyrphostin (1-100 microM) or lavendustin A (0.0001-1 microM), inhibited IL-8 production elicited by IL-1 beta. However, the macrolide protein kinase inhibitor geldanamycin (IC50 = 30 nM), but not the closely related analog herbimycin A (5-500 nM), inhibited IL-8 production by 60%. Northern blot analysis of IL-8 mRNA revealed that staurosporine suppressed mRNA increase following stimulation by PMA but not by IL-1. It is proposed that a novel protein kinase susceptible to geldanamycin inhibition may be involved in IL-1-mediated signal transduction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8273591     DOI: 10.1007/bf01972725

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  8 in total

1.  How does interleukin 1 activate cells? Cyclic AMP and interleukin 1 signal transduction.

Authors:  S B Mizel
Journal:  Immunol Today       Date:  1990-11

2.  Enhancement of cAMP levels and of protein kinase activity by tumor necrosis factor and interleukin 1 in human fibroblasts: role in the induction of interleukin 6.

Authors:  Y H Zhang; J X Lin; Y K Yip; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

3.  IL-1 signaling for IL-2 production in T cells involves a rise in phosphatidylserine synthesis.

Authors:  M Didier; C Aussel; C Pelassy; M Fehlmann
Journal:  J Immunol       Date:  1988-11-01       Impact factor: 5.422

4.  The role of protein kinase C in interleukin 1 and tumor necrosis factor alpha induction of fibroblasts to produce and release granulocyte-macrophage colony-stimulating activity.

Authors:  J R Zucali; C Morse; C A Dinarello
Journal:  Exp Hematol       Date:  1990-09       Impact factor: 3.084

5.  Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1).

Authors:  T Yoshimura; K Matsushima; J J Oppenheim; E J Leonard
Journal:  J Immunol       Date:  1987-08-01       Impact factor: 5.422

Review 6.  Interleukin-1 and interleukin-1 antagonism.

Authors:  C A Dinarello
Journal:  Blood       Date:  1991-04-15       Impact factor: 22.113

7.  Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions.

Authors:  M A Gimbrone; M S Obin; A F Brock; E A Luis; P E Hass; C A Hébert; Y K Yip; D W Leung; D G Lowe; W J Kohr
Journal:  Science       Date:  1989-12-22       Impact factor: 47.728

8.  Monokine-induced neutrophil chemotactic factor gene expression in human fibroblasts.

Authors:  R M Strieter; S H Phan; H J Showell; D G Remick; J P Lynch; M Genord; C Raiford; M Eskandari; R M Marks; S L Kunkel
Journal:  J Biol Chem       Date:  1989-06-25       Impact factor: 5.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.